الصفحة الرئيسية>>Signaling Pathways>> Proteases>> Endogenous Metabolite>>Coenzyme B12

Coenzyme B12

رقم الكتالوجGC43296

إنزيم B12 (الإنزيم المساعد B12 ؛ كوباميد ؛ AdoCbl) هو شكل نشط من فيتامين B12 وهو عامل مساعد لميثيل مالونيل CoA mutase [1] في المختبر: يعمل الإنزيم المساعد B12 كعامل مساعد لمجموعة من الإنزيمات التي تحفز إعادة الترتيب غير العادية أو تفاعلات الإزالة.

Products are for research use only. Not for human use. We do not sell to patients.

Coenzyme B12 التركيب الكيميائي

Cas No.: 13870-90-1

الحجم السعر المخزون
25mg
40٫00
Please Inquire
100mg
71٫00
Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Coenzyme B12 (adenosylcobalamin; AdoCbl) is a biologically active form of vitamin B12 . It belongs to the corrinoid group of compounds, which contain a corrin macrocycle, and is produced only by certain bacteria and archaea. It is a cofactor for various enzymes including mutases, eliminases, aminomutases, and a reductase. These enzymes catalyze reactions that generate free radicals through release of the adenosyl group, allowing usually unreactive molecules to become reactive. Only one of these enzymes, methylmalonyl CoA mutase, is found in mammals, therefore, the other enzymes must be taken in through the diet. Genetic mutations in enzymes that synthesize AdoCbl lead to AdoCbl deficiency and methylmalonic aciduria. Formulations containing AdoCbl are used to treat patients with this disorder.

مراجعات

Review for Coenzyme B12

Average Rating: 5 ★★★★★ (Based on Reviews and 6 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Coenzyme B12

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.